Amwill Health Care
AMWILLHEALTHCARELTD NSE
Amwill Health Care
HealthcareNSE: AMWILLHEALTHCARELTD BSE: 544353 Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹86.00 Cr
Volatility
Moderate
P/E Ratio
7.5
EBITDA
₹15.90 Cr
Return on Equity
14.17%
Debt to Equity
0
Book Value
₹40.28
52W High
₹62.99
52W Low
₹28.91
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
4- Company is almost debt free.
- Stock is trading at 1.07 times its book value
- Company has delivered good profit growth of 68.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.9%
Weaknesses
1- Company has high debtors of 177 days.
Growth Rate
Revenue Growth
17.19% higher than
3Y
Net Income Growth
6.54% lower than
3Y
Cash Flow Change
43.88% lower than
3Y
ROE
-8.58% lower than
3Y
ROCE
10.92% higher than
3Y
EBITDA Margin (Avg.)
9.82% higher than
3Y
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 23 | 17 | 21 | 24 |
| Expenses | 14 | 15 | 17 | 15 |
| Operating Profit | 9 | 3 | 4 | 9 |
| OPM % | 38% | 16% | 19% | 37% |
| Other Income | 0 | 1 | 1 | 2 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| PBT | 9 | 3 | 5 | 10 |
| Tax % | 26% | -34% | 26% | 25% |
| Net Profit | 7 | 4 | 4 | 8 |
| EPS in Rs | 4.18 | 2.1 | 1.93 | 3.77 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 17 | 26 | 28 | 42 | 37 | 43 |
| Expenses | 18 | 22 | 24 | 25 | 26 | 30 |
| Operating Profit | -1 | 4 | 4 | 17 | 12 | 13 |
| OPM % | -6% | 14% | 15% | 40% | 31% | 30% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 |
| PBT | -1 | 3 | 4 | 17 | 12 | 15 |
| Tax % | -3% | 23% | 25% | 25% | 10% | 26% |
| Net Profit | -1 | 3 | 3 | 12 | 11 | 11 |
| EPS in Rs | -333 | 857 | 1,037 | 2,500 | 5.36 | 5.71 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 9% |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 0.03 | 0.05 | 20 | 20 |
| Reserves | -1 | 1 | 5 | 17 | 49 | 61 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 9 | 5 | 8 | 2 | 2 | 6 |
| Total Liabilities | 8 | 7 | 12 | 19 | 71 | 87 |
| Fixed Assets | 1 | 0 | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 3 |
| Other Assets | 7 | 6 | 12 | 18 | 70 | 83 |
| Total Assets | 8 | 7 | 12 | 19 | 71 | 87 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 0 | 3 | 5 | -3 | 6 | 8 |
| Investing | -1 | 0 | -1 | -1 | -46 | 6 |
| Financing | 0 | 0 | 0 | 0 | 41 | 0 |
| Net Cash Flow | -1 | 3 | 3 | -4 | 1 | 14 |
| Free Cash Flow | -1 | 3 | 4 | -4 | 5 | 7 |
| CFO/OP | -26 | 108 | 135 | 6 | 62 | 88 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 93 | 12 | 16 | 114 | 163 | 177 |
| Inventory Days | — | — | — | 66 | — | — |
| Days Payable | — | — | — | 39 | — | — |
| Cash Conversion Cycle | 93 | 12 | 16 | 141 | 163 | 177 |
| Working Capital Days | -45 | -25 | -38 | 111 | 166 | 158 |
| ROCE % | — | 1069% | 133% | 153% | 28% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Amwill Health Care insights
38 extracted metrics + investor summaries across FY17–FY26.
Documents
1
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for 4th Quarter ended March 31, 2026 of FY 2025-26. 9 Apr - Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for 4th Quarter ended March 31, 2026 of FY 2025-26.
2
Update On Prior Intimation Regarding Cyber Security Incident.
7 Apr - Cybersecurity incident from Feb. 18, 2026 led to SDD data loss; entries restored and certified. 7 Apr - Cybersecurity incident from Feb. 18, 2026 led to SDD data loss; entries restored and certified.
4
Completion Of Early Redemption Of Non-Convertible Debentures
18h - Redeemed 45,000 11% secured NCDs (ISIN INE149K07013) totaling ₹423 crore on 9 Mar 2026. 18h - Redeemed 45,000 11% secured NCDs (ISIN INE149K07013) totaling ₹423 crore on 9 Mar 2026.
5
Intimation Of IT Security Incident
18 Feb - Cybersecurity incident impacting account-related data since 30 Sep 2025; systems isolated, investigation and remediation underway. 18 Feb - Cybersecurity incident impacting account-related data since 30 Sep 2025; systems isolated, investigation and remediation underway.
Frequently Asked Questions about Amwill Health Care
What does Amwill Health Care Ltd do?
Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products[1]
Where is Amwill Health Care Ltd (544353) listed?
Amwill Health Care Ltd trades as AMWILLHEALTHCARELTD on the NSE and under code 544353 on the BSE.
Which sector does Amwill Health Care Ltd belong to?
Amwill Health Care Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Amwill Health Care Ltd?
Amwill Health Care Ltd has a market capitalisation of ₹86 Cr, which places it in the Small Cap band.
What is the PE ratio of Amwill Health Care Ltd?
Amwill Health Care Ltd trades at a PE ratio of 7.50, against a book value of ₹40.28 per share.
What is the 52-week high and low of Amwill Health Care Ltd?
Over the last 52 weeks Amwill Health Care Ltd has traded between ₹28.91 and ₹62.99.
Does Amwill Health Care Ltd pay dividends?
Amwill Health Care Ltd has a dividend yield of 1.16%.
What is the Return on Equity (ROE) of Amwill Health Care Ltd?
Amwill Health Care Ltd reported a return on equity of 14.17%. Its debt-to-equity ratio is 0.00.
Company Information
Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544353.md for Amwill Health Care Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.